I
Inspire Medical Systems
Manufacturer of the world’s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea.
At a glance
- Status
- Listed
- Listing
- IPO 2018
News
Open roles
Inspire Medical Systems in the Golden Valley ecosystem
The Inspire Medical Systems office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series B and later6 investors entered at this stage
- SPSynergy Life Science Partner
- TVTGap Ventures
- APAperture Venture Partners
OrbiMed- MEMedtronic
- AMAmzak Capital Management
Source: Dealroom Talent Intelligence.
Patents
101 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Inspire Medical Systems was the backer or acquirer, 2022–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Inspire Medical Systems's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Inspire Medical Systems deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Inspire Medical Systems's portfolio, mapped.
See Inspire Medical Systems on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


